Company / Revenue
GT Biopharma, Inc. Revenue History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2020
5-year range
$0 / $368.0K
FY2016-FY2020
Trend
-
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $27,000 to $0 over the past 4 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0 | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $27.0K | -55.7% |
| FY2015 | $61.0K | -83.4% |
| FY2014 | $368.0K | +7.6% |
| FY2013 | $342.0K | +1215.4% |
| FY2012 | $26.0K | +136.4% |
| FY2011 | $11.0K | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026